XML 39 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Options Granted under Company's Stock Incentive Plans, Valuation Assumptions and Fair Values

Options granted under the Company’s stock incentive plans were valued utilizing the Black-Scholes model using the following assumptions and had the following fair values:

 

    

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

    

2017

  

2016

  

2017

  

2016

Average risk-free interest rate

   1.56%    0.84%    1.52%    0.87%

Expected dividend yield

   None    None    None    None

Expected life

   3.5 years    3.5 years    3.5 years    3.5 years

Expected volatility

   64.2% to 67.0%    68.6% to 75.3%    64.2% to 72.0%    68.6% to 75.3%

Weighted average exercise price

   $4.28    $5.49    $4.39    $5.57

Weighted average fair value

   $2.02    $2.67    $2.12    $2.71
Stock-Based Compensation Expense Including Options and Restricted Stock by Category

The Company’s stock-based compensation expense, including options and restricted stock by category is as follows (in thousands):

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2017      2016      2017      2016  

Cost of revenue

   $ 1      $ 1        5      $ 5  

Engineering and product development

     76        82        633        289  

Marketing and sales

     132        162        854        476  

General and administrative

     294        201        1,581        878  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 503      $ 446      $ 3,073      $ 1,648  
  

 

 

    

 

 

    

 

 

    

 

 

 
Unrecognized Compensation Cost Related to Unexercisable Options and Unvested Restricted Stock and Weighted Average Remaining Period

As of September 30, 2017, unrecognized compensation cost (in thousands) related to unexercisable options and unvested restricted stock and the weighted average remaining period is as follows:

 

Remaining expense

   $ 2,504  

Weighted average term

     1.1 years  
Aggregate Intrinsic Value

The Company’s aggregate intrinsic value for stock options and restricted stock outstanding is as follows (in thousands):

 

     Period Ended
September 30,
 

Aggregate intrinsic value

   2017      2016  

Stock options

   $ 1,050      $ 1,748  

Restricted stock

     2,242        2,039